Sharma Supriya, Rathi Anubha, Murthy Somasheila I, Trivedi Mihika, Patel Chaitali, Mohamed Ashik, Chaurasia Sunita
The Cornea Institute, LV Prasad Eye Institute, Hyderabad, India; and.
Ophthalmic Biophysics, LV Prasad Eye Institute, Hyderabad, India.
Cornea. 2021 May 1;40(5):618-623. doi: 10.1097/ICO.0000000000002529.
To report the indications, long-term structural and functional outcomes, and prognostic factors for the success of penetrating and lamellar corneal patch grafts.
This is a retrospective analysis of 49 patients who underwent the corneal patch graft procedure over 8 years. The baseline, preoperative, and postoperative characteristics along with their outcomes were evaluated.
Forty-nine eyes (49 patients) with a mean follow-up of 20.3 ± 3.27 months (range 6-48) were included. Thirty-one patients underwent full-thickness grafts for corneal perforation, and 18 underwent lamellar grafts for severe thinning. The most common indication was corneal thinning and/or perforation secondary to microbial keratitis (17 eyes, 34.7%). Anatomic success was achieved in 31 eyes (63.2%), in which no further surgical intervention was required for tectonicity. Functional success was achieved in 22 of 37 eyes (59.5%), where along with anatomic success, significant visual gain was also obtained. Absolute graft failure was noted in 12 eyes (24.5%), which developed recurrence of primary pathology requiring reintervention within the first 6 months. Good prognostic factor for success included sterile corneal perforations. The presence of microbial keratitis was noted to be a guarded prognostic factor for success.
Corneal patch graft can serve as a good therapeutic modality for corneal ulceration or thinning, not amenable to treatment with tissue adhesive application. Both anatomical success and functional success of 60% was achieved in our series. Those performed for immune-mediated conditions fared the best. Subsequent optical procedures may be performed for further visual rehabilitation at a later stage.
报告穿透性和板层角膜移植片移植成功的适应证、长期结构和功能结果以及预后因素。
这是一项对49例在8年期间接受角膜移植片移植手术患者的回顾性分析。评估了基线、术前和术后特征及其结果。
纳入49只眼(49例患者),平均随访20.3±3.27个月(范围6 - 48个月)。31例患者因角膜穿孔接受全层移植,18例因严重角膜变薄接受板层移植。最常见的适应证是继发于微生物性角膜炎的角膜变薄和/或穿孔(17只眼,34.7%)。31只眼(63.2%)获得了解剖学成功,即无需进一步手术干预来维持角膜结构。37只眼中的22只眼(59.5%)获得了功能成功,即除解剖学成功外,还获得了显著的视力提高。12只眼(24.5%)出现绝对移植失败,在最初6个月内原发性病变复发需要再次干预。成功的良好预后因素包括无菌性角膜穿孔。微生物性角膜炎的存在被认为是成功的一个预后不佳因素。
角膜移植片移植可作为角膜溃疡或变薄的一种良好治疗方式,不适用于组织黏合剂治疗。在我们的系列研究中,解剖学成功和功能成功均达到60%。那些针对免疫介导疾病进行的手术效果最佳。后续可在后期进行进一步的光学手术以实现进一步的视力康复。